St. Ives Authorized to Repurchase 250,000 Shares
- Share via
Directors of St. Ives Laboratories authorized the company during the next year to repurchase up to 250,000, or 3.5%, of its 7.1 million common shares outstanding.
St. Ives, a Chatsworth-based maker of shampoos and other personal-care products, joins scores of other U.S. companies that have announced stock-buyback plans to bolster their stock prices following the Oct. 19 market crash.
The crash came three months after St. Ives went public at $13 per share.
St. Ives said its stock’s price, which was $6.75 at the close of trading Monday, is undervalued and thus represents an attractive investment. St. Ives also said the repurchased shares would be used for its employees’ stock option plan.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
